Suppr超能文献

血小板因子4与肝素寡糖的结合。

Binding of platelet factor 4 to heparin oligosaccharides.

作者信息

Denton J, Lane D A, Thunberg L, Slater A M, Lindahl U

出版信息

Biochem J. 1983 Feb 1;209(2):455-60. doi: 10.1042/bj2090455.

Abstract

Heparin fractions of differing Mr (7800-18 800) prepared from commercial heparin by gel filtration and affinity chromatography on immobilized anti-thrombin III had specific activities when determined by anti-Factor Xa and anti-thrombin assays that ranged from 228 to 448 units/mg. The anti-Factor Xa activity of these fractions could be readily and totally neutralized by increasing concentrations of platelet factor 4 (PF4). That these fractions bound to immobilized PF4 was indicated by the complete binding under near physiological conditions of 3H-labelled unfractionated commercial heparin. An anti-thrombin III-binding oligosaccharide preparation (containing predominantly eight to ten saccharide units), prepared by degradation of heparin with HNO2 had high (800 units/mg) anti-Factor Xa, but negligible anti-thrombin, specific activity. The anti-Factor Xa activity of this material could not be readily neutralized by PF4, and the 3H-labelled oligosaccharides did not completely bind to immobilized PF4. A heterogeneous anti-thrombin III-binding preparation containing upwards of 16 saccharides had anti-thrombin specific activity of just less than one-half the anti-Factor Xa specific activity. This material was completely bound to immobilized PF4 and was eluted with similar concentrations of NaCl to those that were required to elute unfractionated heparins from these columns. Furthermore, increasing concentrations of PF4 neutralized the anti-Factor Xa activity of this material in a manner similar to that of unfractionated heparin. It is concluded that heparin oligosaccharides require saccharide units in addition to the anti-thrombin III-binding sequence in order to fully interact with PF4.

摘要

通过凝胶过滤和在固定化抗凝血酶III上进行亲和色谱法,从商业肝素制备出不同相对分子质量(7800 - 18800)的肝素级分,通过抗Xa因子和抗凝血酶测定法测定其比活性,范围为228至448单位/毫克。随着血小板因子4(PF4)浓度的增加,这些级分的抗Xa因子活性能够很容易且完全被中和。3H标记的未分级商业肝素在接近生理条件下完全结合,这表明这些级分与固定化PF4结合。用HNO2降解肝素制备的一种抗凝血酶III结合寡糖制剂(主要含有八至十个糖单元)具有高的(800单位/毫克)抗Xa因子活性,但抗凝血酶比活性可忽略不计。该物质的抗Xa因子活性不能被PF4轻易中和,并且3H标记的寡糖不能完全结合到固定化PF4上。一种含有超过16个糖的异质性抗凝血酶III结合制剂,其抗凝血酶比活性仅略低于抗Xa因子比活性的一半。该物质完全结合到固定化PF4上,并用与从这些柱上洗脱未分级肝素所需浓度相似的NaCl浓度进行洗脱。此外,随着PF4浓度的增加,该物质的抗Xa因子活性以与未分级肝素类似的方式被中和。得出的结论是,肝素寡糖除了抗凝血酶III结合序列外还需要糖单元,以便与PF4充分相互作用。

相似文献

6
Mechanism of low-molecular-weight heparin reversal by platelet factor 4.血小板第4因子对低分子量肝素的逆转机制。
Thromb Res. 2009 May;124(1):149-55. doi: 10.1016/j.thromres.2008.12.047. Epub 2009 Feb 4.

引用本文的文献

8
Exposure to acrolein by inhalation causes platelet activation.吸入丙烯醛会导致血小板活化。
Toxicol Appl Pharmacol. 2010 Oct 15;248(2):100-10. doi: 10.1016/j.taap.2010.07.013. Epub 2010 Aug 3.
9
Slow thrombin is zymogen-like.慢凝血酶类似酶原。
J Thromb Haemost. 2009 Jul;7 Suppl 1(S1STATE):159-64. doi: 10.1111/j.1538-7836.2009.03365.x.

本文引用的文献

1
A method for the determination of heparin in blood.一种测定血液中肝素的方法。
J Physiol. 1949 Aug;109(1-2):41-8. doi: 10.1113/jphysiol.1949.sp004367.
2
Studies on fractionated heparin.关于分次肝素的研究。
Arch Biochem Biophys. 1961 Feb;92:224-31. doi: 10.1016/0003-9861(61)90341-1.
8
The anti-heparin properties of human low-density lipoprotein.
Biochim Biophys Acta. 1980 Mar 21;617(3):472-9. doi: 10.1016/0005-2760(80)90013-2.
10
Multiple functional domains of the heparin molecule.肝素分子的多个功能域。
Proc Natl Acad Sci U S A. 1981 Feb;78(2):829-33. doi: 10.1073/pnas.78.2.829.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验